Our Objectives

 

To strengthen Germany as a location for the pharmaceutical industry

For a long time, Germany was the "pharmacy for the world," but today our member companies have to face global competition. They make investments without receiving subsidies, offer secure employment and contribute significantly to Germany's foreign trade balance. This will not change in the future.

However, excessive regulation and continued cost abatement policy in the German health care sector are jeopardizing this objective. It is becoming increasingly difficult for the research-based pharmaceutical companies to generate the large research and development costs of innovative pharmaceuticals in the German market.

It is now becoming apparent that government intervention will not solve the problems of the health care sector. This is noticed primarily by the patients whose medical care is increasingly negatively.

Best possible health care at the lowest possible cost can only be achieved through increased competition within the health care sector. More competition among service providers and suppliers is also the prerequisite for being able to use the economic opportunities of the health care sector as a growing market.